Trial Profile
An Open-Label Study to Evaluate 18F ML-10 as a PET Imaging Radiotracer for Early Detection of Response of Brain Metastases to Whole Brain Radiation Therapy (WBRT)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Apr 2014
Price :
$35
*
At a glance
- Drugs Fluorine-18 ML 10 (Primary)
- Indications Brain metastases
- Focus Diagnostic use
- Sponsors Aposense
- 03 Apr 2014 New trial record